Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1976

1.

Relationship between X-ray findings of lumbar spondylosis and knee pain.

Uehara K, Akai M, Doi T, Oka H, Iwaya T.

BMC Musculoskelet Disord. 2019 Aug 17;20(1):379. doi: 10.1186/s12891-019-2755-1.

2.

Knockout of pgdS and ggt gene changes poly-γ-glutamic acid production in Bacillus licheniformis RK14-46.

Ojima Y, Kobayashi J, Doi T, Azuma M.

J Biotechnol. 2019 Aug 9. pii: S0168-1656(19)30812-0. doi: 10.1016/j.jbiotec.2019.08.003. [Epub ahead of print]

PMID:
31404564
3.

Spontaneous globule leukocyte tumor accompanied by inflammatory cells in a Wistar Hannover rat.

Sato J, Tomonari Y, Doi T, Tsuchitani M.

J Toxicol Pathol. 2019 Jul;32(3):189-195. doi: 10.1293/tox.2018-0068. Epub 2019 May 27.

4.

U3-1402, a novel HER3-targeting antibody-drug conjugate, for the treatment of Colorectal Cancer.

Koganemaru S, Kuboki Y, Koga Y, Kojima T, Yamauchi M, Maeda N, Kagari T, Hirotani K, Yasunaga M, Matsumura Y, Doi T.

Mol Cancer Ther. 2019 Aug 8. pii: molcanther.0452.2019. doi: 10.1158/1535-7163.MCT-19-0452. [Epub ahead of print]

PMID:
31395690
5.

Combination therapy with traditional medicines for perianal abscess in children.

Sueyoshi R, Lane GJ, Kusafuka J, Yamataka A, Doi T.

Pediatr Int. 2019 Aug 8. doi: 10.1111/ped.13988. [Epub ahead of print]

PMID:
31394015
6.

High-normal albuminuria is associated with subclinical atherosclerosis in male population with estimated glomerular filtration rate ≥60 mL/min/1.73 m2: A cross-sectional study.

Kimura T, Ueno T, Doi S, Nakashima A, Doi T, Ashitani A, Kawano R, Yamane K, Masaki T.

PLoS One. 2019 Aug 1;14(8):e0218290. doi: 10.1371/journal.pone.0218290. eCollection 2019.

7.

Study protocol of the self-monitoring activity program: Effects of activity on incident dementia.

Shimada H, Lee S, Doi T, Bae S, Makino K, Chiba I, Arai H.

Alzheimers Dement (N Y). 2019 Jul 18;5:303-307. doi: 10.1016/j.trci.2019.05.009. eCollection 2019.

8.

Does the conventional landmark help to place the tip of REBOA catheter in the optimal position? A non-controlled comparison study.

Nakajima K, Taniguchi H, Abe T, Yamaguchi K, Doi T, Takeuchi I, Morimura N.

World J Emerg Surg. 2019 Jul 16;14:35. doi: 10.1186/s13017-019-0255-0. eCollection 2019.

9.

First-in-human phase 1 study of IT1208, a defucosylated humanized anti-CD4 depleting antibody, in patients with advanced solid tumors.

Shitara K, Ueha S, Shichino S, Aoki H, Ogiwara H, Nakatsura T, Suzuki T, Shimomura M, Yoshikawa T, Shoda K, Kitano S, Yamashita M, Nakayama T, Sato A, Kuroda S, Wakabayashi M, Nomura S, Yokochi S, Ito S, Matsushima K, Doi T.

J Immunother Cancer. 2019 Jul 24;7(1):195. doi: 10.1186/s40425-019-0677-y.

10.

Association of sleep condition and social frailty in community-dwelling older people.

Nakakubo S, Doi T, Makizako H, Tsutsumimoto K, Kurita S, Kim M, Ishii H, Suzuki T, Shimada H.

Geriatr Gerontol Int. 2019 Jul 18. doi: 10.1111/ggi.13734. [Epub ahead of print]

PMID:
31321900
11.

Structural development of 1H-pyrazolo-[3,4-b]pyridine-4-carboxylic acid derivatives as human peroxisome proliferator-activated receptor alpha (PPARα)-selective agonists.

Miyachi H, Yuzuriha T, Tabata R, Fukuda S, Nunomura K, Lin B, Kobayashi T, Ishimoto K, Doi T, Tachibana K.

Bioorg Med Chem Lett. 2019 Aug 15;29(16):2124-2128. doi: 10.1016/j.bmcl.2019.06.062. Epub 2019 Jul 4.

PMID:
31320147
12.

Impact of Social Frailty on Alzheimer's Disease Onset: A 53-Month Longitudinal Cohort Study.

Tsutsumimoto K, Doi T, Nakakubo S, Kim M, Kurita S, Ishii H, Shimada H, Kawachi I.

J Alzheimers Dis. 2019;70(2):587-595. doi: 10.3233/JAD-181178.

PMID:
31256123
13.

Anthracycline could be essential for triple-negative breast cancer: A randomised phase II study by the Kanagawa Breast Oncology Group (KBOG) 1101.

Narui K, Ishikawa T, Shimizu D, Yamada A, Tanabe M, Sasaki T, Oba MS, Morita S, Nawata S, Kida K, Mogaki M, Doi T, Tsugawa K, Ogata H, Ota T, Kosaka Y, Sengoku N, Kuranami M, Niikura N, Saito Y, Suzuki Y, Suto A, Arioka H, Chishima T, Ichikawa Y, Endo I, Tokuda Y.

Breast. 2019 Jun 15;47:1-9. doi: 10.1016/j.breast.2019.06.003. [Epub ahead of print]

PMID:
31229857
14.

Phase I study of ipatasertib as a single agent and in combination with abiraterone plus prednisolone in Japanese patients with advanced solid tumors.

Doi T, Fujiwara Y, Matsubara N, Tomomatsu J, Iwasa S, Tanaka A, Endo-Tsukude C, Nakagawa S, Takahashi S.

Cancer Chemother Pharmacol. 2019 Aug;84(2):393-404. doi: 10.1007/s00280-019-03882-7. Epub 2019 Jun 21.

15.

Bone mineral density is increased in the cadmium-induced omphalocele chick model by using three-dimensional micro-computed tomography.

Shigeta Y, Fujiwara N, Koike M, Yamataka A, Doi T.

Pediatr Surg Int. 2019 Aug;35(8):911-914. doi: 10.1007/s00383-019-04501-5. Epub 2019 Jun 15.

PMID:
31203385
16.

microRNA-200c regulates KLOTHO expression in human kidney cells under oxidative stress.

Morii K, Yamasaki S, Doi S, Irifuku T, Sasaki K, Doi T, Nakashima A, Arihiro K, Masaki T.

PLoS One. 2019 Jun 14;14(6):e0218468. doi: 10.1371/journal.pone.0218468. eCollection 2019.

17.

Identification of Celastramycin as a Novel Therapeutic Agent for Pulmonary Arterial Hypertension.

Kurosawa R, Satoh K, Kikuchi N, Kikuchi H, Saigusa D, Al-Mamun ME, Siddique MAH, Omura J, Satoh T, Sunamura S, Nogi M, Numano K, Miyata S, Uruno A, Kano K, Matsumoto Y, Doi T, Aoki J, Oshima Y, Yamamoto M, Shimokawa H.

Circ Res. 2019 Jul 19;125(3):309-327. doi: 10.1161/CIRCRESAHA.119.315229. Epub 2019 Jun 14.

PMID:
31195886
18.

Early administration of adalimumab for paediatric uveitis due to Behçet's disease.

Hiyama T, Harada Y, Doi T, Kiuchi Y.

Pediatr Rheumatol Online J. 2019 Jun 10;17(1):29. doi: 10.1186/s12969-019-0333-6.

19.

Efficacy of perioperative chemotherapy for pulmonary high-grade neuroendocrine carcinomas: a propensity score matching analysis.

Ogawa H, Tanaka Y, Kitamura Y, Shimizu N, Doi T, Hokka D, Tane S, Nishio W, Yoshimura M, Maniwa Y.

J Thorac Dis. 2019 Apr;11(4):1145-1154. doi: 10.21037/jtd.2019.04.56.

20.

Atypical reduction of plasma ADAMTS13 activity by a non-IgG-type inhibitor in a patient with hemolytic uremic syndrome caused by Shiga toxin-producing Escherichia coli.

Nakayama S, Hirashio S, Yorishima H, Doi T, Yoshida Y, Matsumoto M, Masaki T.

CEN Case Rep. 2019 Jun 8. doi: 10.1007/s13730-019-00405-4. [Epub ahead of print]

21.

Whitening Efficacy of Chewing Gum Containing Sodium Metaphosphate on Coffee Stain: Placebo-controlled, Double-blind In Situ Examination.

Makino S, Kawamoto C, Ikeda T, Doi T, Narise A, Tanaka T, Almas C, Hannig M, Carvalho R, Sano H.

Oper Dent. 2019 Jun 7. doi: 10.2341/17-385-C. [Epub ahead of print]

PMID:
31172873
22.

Physical Performance Predictors for Incident Dementia Among Japanese Community-Dwelling Older Adults.

Doi T, Tsutsumimoto K, Nakakubo S, Kim MJ, Kurita S, Hotta R, Shimada H.

Phys Ther. 2019 Jun 4. pii: pzz077. doi: 10.1093/ptj/pzz077. [Epub ahead of print]

PMID:
31162614
23.

Involvement of Elf3 on Smad3 activation-dependent injuries in podocytes and excretion of urinary exosome in diabetic nephropathy.

Sakurai A, Ono H, Ochi A, Matsuura M, Yoshimoto S, Kishi S, Murakami T, Tominaga T, Nagai K, Abe H, Doi T.

PLoS One. 2019 May 31;14(5):e0216788. doi: 10.1371/journal.pone.0216788. eCollection 2019.

24.

Development and validation of Comprehensive Gait Assessment using InerTial Sensor score (C-GAITS score) derived from acceleration and angular velocity data at heel and lower trunk among community-dwelling older adults.

Misu S, Asai T, Doi T, Sawa R, Ueda Y, Murata S, Saito T, Sugimoto T, Isa T, Tsuboi Y, Yamada M, Ono R.

J Neuroeng Rehabil. 2019 May 28;16(1):62. doi: 10.1186/s12984-019-0539-3.

25.

Clinical significance of soluble forms of immune checkpoint molecules in advanced esophageal cancer.

Yoshida J, Ishikawa T, Doi T, Ota T, Yasuda T, Okayama T, Sakamoto N, Inoue K, Dohi O, Yoshida N, Kamada K, Uchiyama K, Takagi T, Konishi H, Naito Y, Itoh Y.

Med Oncol. 2019 May 27;36(7):60. doi: 10.1007/s12032-019-1285-x.

PMID:
31134385
26.

A Comparison of Laparoscopic Redo Fundoplications for Failed Toupet and Nissen Fundoplications in Children.

Miyano G, Yamoto M, Miyake H, Morita K, Kaneshiro M, Nouso H, Koyama M, Okawada M, Doi T, Koga H, Lane GJ, Fukumoto K, Yamataka A, Urushihara N.

J Indian Assoc Pediatr Surg. 2019 Apr-Jun;24(2):100-103. doi: 10.4103/jiaps.JIAPS_228_17.

27.

Total Synthesis and Structural Revision of Cyclotetrapeptide Asperterrestide A.

Ohsawa K, Sugai M, Zhang L, Masuda Y, Yoshida M, Doi T.

J Org Chem. 2019 Jun 7;84(11):6765-6779. doi: 10.1021/acs.joc.9b00526. Epub 2019 May 22.

PMID:
31070032
28.

The utility and limitation of inferior vena cava diameter as a dry weight marker.

Shibata E, Nagai K, Ueda S, Ono H, Nishimura K, Inagaki T, Minato M, Kishi F, Tamaki M, Murakami T, Kishi S, Abe H, Yokota N, Minakuchi J, Doi T.

J Med Invest. 2019;66(1.2):172-177. doi: 10.2152/jmi.66.172.

29.

Total Synthesis of Pactalactam, an Imidazolidinone-Type Pactamycin Analogue.

Kim T, Matsushita S, Matsudaira S, Doi T, Hirota S, Park YT, Igarashi M, Hatano M, Ikeda N, Ham J, Nakata M, Saikawa Y.

Org Lett. 2019 May 17;21(10):3554-3557. doi: 10.1021/acs.orglett.9b00905. Epub 2019 May 6.

PMID:
31058517
30.

Trastuzumab deruxtecan (DS-8201a) in patients with advanced HER2-positive gastric cancer: a dose-expansion, phase 1 study.

Shitara K, Iwata H, Takahashi S, Tamura K, Park H, Modi S, Tsurutani J, Kadowaki S, Yamaguchi K, Iwasa S, Saito K, Fujisaki Y, Sugihara M, Shahidi J, Doi T.

Lancet Oncol. 2019 Jun;20(6):827-836. doi: 10.1016/S1470-2045(19)30088-9. Epub 2019 Apr 29. Erratum in: Lancet Oncol. 2019 May 10;:.

PMID:
31047804
31.

Trastuzumab deruxtecan (DS-8201a) in patients with advanced HER2-positive breast cancer previously treated with trastuzumab emtansine: a dose-expansion, phase 1 study.

Tamura K, Tsurutani J, Takahashi S, Iwata H, Krop IE, Redfern C, Sagara Y, Doi T, Park H, Murthy RK, Redman RA, Jikoh T, Lee C, Sugihara M, Shahidi J, Yver A, Modi S.

Lancet Oncol. 2019 Jun;20(6):816-826. doi: 10.1016/S1470-2045(19)30097-X. Epub 2019 Apr 29. Erratum in: Lancet Oncol. 2019 May 10;:.

PMID:
31047803
32.

A phase 1 study of oral ASP5878, a selective small-molecule inhibitor of fibroblast growth factor receptors 1-4, as a single dose and multiple doses in patients with solid malignancies.

Yamamoto N, Ryoo BY, Keam B, Kudo M, Lin CC, Kunieda F, Ball HA, Moran D, Komatsu K, Takeda K, Fukuda M, Furuse J, Morita S, Doi T.

Invest New Drugs. 2019 Apr 30. doi: 10.1007/s10637-019-00780-w. [Epub ahead of print]

PMID:
31041575
33.

Molecular Basis of Mannose Recognition by Pradimicins and their Application to Microbial Cell Surface Imaging.

Nakagawa Y, Doi T, Takegoshi K, Sugahara T, Akase D, Aida M, Tsuzuki K, Watanabe Y, Tomura T, Ojika M, Igarashi Y, Hashizume D, Ito Y.

Cell Chem Biol. 2019 Jul 18;26(7):950-959.e8. doi: 10.1016/j.chembiol.2019.03.013. Epub 2019 Apr 25.

PMID:
31031141
34.

Lumbar mechanical traction: a biomechanical assessment of change at the lumbar spine.

Tadano S, Tanabe H, Arai S, Fujino K, Doi T, Akai M.

BMC Musculoskelet Disord. 2019 Apr 9;20(1):155. doi: 10.1186/s12891-019-2545-9.

35.

A case of cardiogenic shock due to acute coronary syndrome successfully recovered by percutaneous and paracorporeal left ventricular assist device.

Nakamura M, Hori M, Nakagaito M, Kuwahara H, Kinoshita O, Ono M, Yokoyama S, Doi T, Fukahara K, Kinugawa K.

J Artif Organs. 2019 Sep;22(3):249-252. doi: 10.1007/s10047-019-01101-x. Epub 2019 Apr 1.

PMID:
30937678
36.

Pembrolizumab alone or in combination with chemotherapy as first-line therapy for patients with advanced gastric or gastroesophageal junction adenocarcinoma: results from the phase II nonrandomized KEYNOTE-059 study.

Bang YJ, Kang YK, Catenacci DV, Muro K, Fuchs CS, Geva R, Hara H, Golan T, Garrido M, Jalal SI, Borg C, Doi T, Yoon HH, Savage MJ, Wang J, Dalal RP, Shah S, Wainberg ZA, Chung HC.

Gastric Cancer. 2019 Jul;22(4):828-837. doi: 10.1007/s10120-018-00909-5. Epub 2019 Mar 25.

37.

Encapsulation and controlled release of hydrophobic flavors using biopolymer-based microgel delivery systems: Sustained release of garlic flavor during simulated cooking.

Wang M, Doi T, McClements DJ.

Food Res Int. 2019 May;119:6-14. doi: 10.1016/j.foodres.2019.01.042. Epub 2019 Jan 22.

PMID:
30884694
38.

Diffuse Idiopathic Skeletal Hyperostosis: A Case with Dysphonia, Dysphagia and Myelopathy.

Soejima Y, Arima J, Doi T.

Am J Case Rep. 2019 Mar 17;20:349-353. doi: 10.12659/AJCR.913792.

39.

Reversible predictors of reversion from mild cognitive impairment to normal cognition: a 4-year longitudinal study.

Shimada H, Doi T, Lee S, Makizako H.

Alzheimers Res Ther. 2019 Mar 13;11(1):24. doi: 10.1186/s13195-019-0480-5.

40.

Rethinking the Relationship Between Spatiotemporal Gait Variables and Dementia: A Prospective Study.

Doi T, Tsutsumimoto K, Nakakubo S, Kim MJ, Kurita S, Shimada H.

J Am Med Dir Assoc. 2019 Jul;20(7):899-903. doi: 10.1016/j.jamda.2019.01.134. Epub 2019 Mar 7.

PMID:
30852168
41.

Surgical outcomes of spinal fusion for osteoporotic thoracolumbar vertebral fractures in patients with Parkinson's disease: what is the impact of Parkinson's disease on surgical outcome?

Watanabe K, Katsumi K, Ohashi M, Shibuya Y, Izumi T, Hirano T, Endo N, Kaito T, Yamashita T, Fujiwara H, Nagamoto Y, Matsuoka Y, Suzuki H, Nishimura H, Terai H, Tamai K, Tagami A, Yamada S, Adachi S, Yoshii T, Ushio S, Harimaya K, Kawaguchi K, Yokoyama N, Oishi H, Doi T, Kimura A, Inoue H, Inoue G, Miyagi M, Saito W, Nakano A, Sakai D, Nukaga T, Ikegami S, Shimizu M, Futatsugi T, Ohtori S, Furuya T, Orita S, Imagama S, Ando K, Kobayashi K, Kiyasu K, Murakami H, Yoshioka K, Seki S, Hongo M, Kakutani K, Yurube T, Aoki Y, Oshima M, Takahata M, Iwata A, Endo H, Abe T, Tsukanishi T, Nakanishi K, Watanabe K, Hikata T, Suzuki S, Isogai N, Okada E, Funao H, Ueda S, Shiono Y, Nojiri K, Hosogane N, Ishii K.

BMC Musculoskelet Disord. 2019 Mar 9;20(1):103. doi: 10.1186/s12891-019-2473-8.

42.

Safety and antitumor activity of the anti-PD-1 antibody pembrolizumab in patients with advanced, PD-L1-positive papillary or follicular thyroid cancer.

Mehnert JM, Varga A, Brose MS, Aggarwal RR, Lin CC, Prawira A, de Braud F, Tamura K, Doi T, Piha-Paul SA, Gilbert J, Saraf S, Thanigaimani P, Cheng JD, Keam B.

BMC Cancer. 2019 Mar 4;19(1):196. doi: 10.1186/s12885-019-5380-3.

43.

Development of a Ligand Screening Tool Using Full-Length Human Peroxisome Proliferator-Activated Receptor-Expressing Cell Lines to Ameliorate Metabolic Syndrome.

Tachibana K, Ishimoto K, Takahashi R, Kadono H, Awaji T, Yuzuriha T, Tanaka T, Hamakubo T, Sakai J, Kodama T, Aoki S, Doi T.

Chem Pharm Bull (Tokyo). 2019;67(3):199-202. doi: 10.1248/cpb.c18-00627.

44.

Influence of albumin leakage on glycated albumin in patients with type 2 diabetes undergoing hemodialysis.

Ueda S, Nagai K, Yokota N, Hirose D, Mori H, Noma Y, Doi T, Minakuchi J.

J Artif Organs. 2019 Sep;22(3):264-267. doi: 10.1007/s10047-019-01097-4. Epub 2019 Feb 25.

PMID:
30805746
45.

Role of sea-ice initialization in climate predictability over the Weddell Sea.

Morioka Y, Doi T, Iovino D, Masina S, Behera SK.

Sci Rep. 2019 Feb 25;9(1):2457. doi: 10.1038/s41598-019-39421-w.

46.

How to prevent adverse events of vascular stapling in thoracic surgery: recommendations based on a clinical and experimental study.

Shimizu N, Tanaka Y, Okamoto T, Doi T, Hokka D, Maniwa Y.

J Thorac Dis. 2018 Dec;10(12):6466-6471. doi: 10.21037/jtd.2018.11.14.

47.

Cell-autonomous and redundant roles of Hey1 and HeyL in muscle stem cells: HeyL requires Hes1 to bind diverse DNA sites.

Noguchi YT, Nakamura M, Hino N, Nogami J, Tsuji S, Sato T, Zhang L, Tsujikawa K, Tanaka T, Izawa K, Okada Y, Doi T, Kokubo H, Harada A, Uezumi A, Gessler M, Ohkawa Y, Fukada SI.

Development. 2019 Feb 20;146(4). pii: dev163618. doi: 10.1242/dev.163618.

48.

KEYNOTE-590: Phase III study of first-line chemotherapy with or without pembrolizumab for advanced esophageal cancer.

Kato K, Shah MA, Enzinger P, Bennouna J, Shen L, Adenis A, Sun JM, Cho BC, Özgüroğlu M, Kojima T, Kostorov V, Hierro C, Zhu Y, McLean LA, Shah S, Doi T.

Future Oncol. 2019 Apr;15(10):1057-1066. doi: 10.2217/fon-2018-0609. Epub 2019 Feb 8.

49.

Phase I Study of the Focal Adhesion Kinase Inhibitor BI 853520 in Japanese and Taiwanese Patients with Advanced or Metastatic Solid Tumors.

Doi T, Yang JC, Shitara K, Naito Y, Cheng AL, Sarashina A, Pronk LC, Takeuchi Y, Lin CC.

Target Oncol. 2019 Feb;14(1):57-65. doi: 10.1007/s11523-019-00620-0.

50.

Phase I dose-escalation study of capmatinib (INC280) in Japanese patients with advanced solid tumors.

Esaki T, Hirai F, Makiyama A, Seto T, Bando H, Naito Y, Yoh K, Ishihara K, Kakizume T, Natsume K, Myers A, Doi T.

Cancer Sci. 2019 Apr;110(4):1340-1351. doi: 10.1111/cas.13956. Epub 2019 Feb 20.

Supplemental Content

Support Center